Cargando…

Stem Cell Research Tools in Human Metabolic Disorders: An Overview

Metabolic disorders are very common in the population worldwide and are among the diseases with the highest health utilization and costs per person. Despite the ongoing efforts to develop new treatments, currently, for many of these disorders, there are no approved therapies, resulting in a huge eco...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricci, Serena, Cacialli, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534517/
https://www.ncbi.nlm.nih.gov/pubmed/34685661
http://dx.doi.org/10.3390/cells10102681
_version_ 1784587571977781248
author Ricci, Serena
Cacialli, Pietro
author_facet Ricci, Serena
Cacialli, Pietro
author_sort Ricci, Serena
collection PubMed
description Metabolic disorders are very common in the population worldwide and are among the diseases with the highest health utilization and costs per person. Despite the ongoing efforts to develop new treatments, currently, for many of these disorders, there are no approved therapies, resulting in a huge economic hit and tension for society. In this review, we recapitulate the recent advancements in stem cell (gene) therapy as potential tools for the long-term treatment of both inherited (lysosomal storage diseases) and acquired (diabetes mellitus, obesity) metabolic disorders, focusing on the main promising results observed in human patients and discussing the critical hurdles preventing the definitive jump of this approach from the bench to the clinic.
format Online
Article
Text
id pubmed-8534517
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85345172021-10-23 Stem Cell Research Tools in Human Metabolic Disorders: An Overview Ricci, Serena Cacialli, Pietro Cells Review Metabolic disorders are very common in the population worldwide and are among the diseases with the highest health utilization and costs per person. Despite the ongoing efforts to develop new treatments, currently, for many of these disorders, there are no approved therapies, resulting in a huge economic hit and tension for society. In this review, we recapitulate the recent advancements in stem cell (gene) therapy as potential tools for the long-term treatment of both inherited (lysosomal storage diseases) and acquired (diabetes mellitus, obesity) metabolic disorders, focusing on the main promising results observed in human patients and discussing the critical hurdles preventing the definitive jump of this approach from the bench to the clinic. MDPI 2021-10-07 /pmc/articles/PMC8534517/ /pubmed/34685661 http://dx.doi.org/10.3390/cells10102681 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ricci, Serena
Cacialli, Pietro
Stem Cell Research Tools in Human Metabolic Disorders: An Overview
title Stem Cell Research Tools in Human Metabolic Disorders: An Overview
title_full Stem Cell Research Tools in Human Metabolic Disorders: An Overview
title_fullStr Stem Cell Research Tools in Human Metabolic Disorders: An Overview
title_full_unstemmed Stem Cell Research Tools in Human Metabolic Disorders: An Overview
title_short Stem Cell Research Tools in Human Metabolic Disorders: An Overview
title_sort stem cell research tools in human metabolic disorders: an overview
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534517/
https://www.ncbi.nlm.nih.gov/pubmed/34685661
http://dx.doi.org/10.3390/cells10102681
work_keys_str_mv AT ricciserena stemcellresearchtoolsinhumanmetabolicdisordersanoverview
AT caciallipietro stemcellresearchtoolsinhumanmetabolicdisordersanoverview